2023
Unlocking the Proteome - The NULISA™ Platform
Entrant Company
Halteres Associates
Category
Video - Animation
Client's Name
Alamar Biosciences
Country / Region
United States
Unlocking the Proteome -The NULISA™ Platform sets a new standard in proteomic analysis with attomolar sensitivity, allowing for unprecedented biomarker detection and quantitation.
By leveraging a proprietary sequential immunocomplex capture and release mechanism and the latest advances in Next Generation Sequencing (NGS), the NULISA technology provides both ultra-high sensitivity and scalable multiplexing.
Credits
Entrant Company
Elevate Healthcare
Category
Branded Content - Healthcare & Pharma
Country / Region
United States
Entrant Company
Myovant Sciences
Category
Integrated Marketing - Integrated Marketing Campaign
Country / Region
Switzerland
Entrant Company
NBCUniversal
Category
Video - Internal Communication (NEW)
Country / Region
United States
Entrant Company
PA Consulting
Category
Corporate Identity - Corporate Identity Redesign (NEW)
Country / Region
United Kingdom